Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Harvard Catalyst Profiles is currently experiencing a partial system outage. Login/Edit modules are currently disabled.

Soumitro Pal, Ph.D.

Title
Institution
Department
Address
Phone
Profile Picture

Overview
Major Research Interest:

(a) Roles of different chemokines and chemokine receptors in the progression of human cancers. Recent reports suggest that different chemokines and their receptors play critical role(s) in tumor progression and tumor metastasis. We plan to study the role(s) of oncogenes and some kinases in modulating the expression of different chemokines/chemokine receptors in human breast cancer and renal cancer. Our studies are focused on the signal transduction pathways that are involved in the development and progression of tumor. We have shown that the oncogenic ras pathway can modulate the expression of the splice variants of the chemokine receptor CXCR3, and may play a critical role in the development and rapid progression of cancer (Datta & Pal et al, Cancer Research, 2006).

(b) Mechanism(s) for the development of post-transplantation cancer, and primarily renal and skin cancer. We plan to study the role of different immunosuppressive drugs in modulating the expression of angiogenic cytokines (like vascular endothelial growth factor) and chemokines post-transplantation. We have recently shown that the calcineurin inhibitors (used in transplant patients) can promote rapid progression of human renal cancer through the overexpression of the angiogenic cytokine VEGF (Basu & Pal et al, Cancer Research, 2008; Basu & Pal et al, J Biological Chemistry, 2010). We have also demonstrated that the calcineurin inhibitors can activate the ras oncogenic pathway(s) in human renal cancer cells (Datta & Pal et al, Cancer Research, 2009).

(c) Role of the cytoprotective enzyme heme oxygenase-1 (HO-1) in regulating the expression of different genes for the effective repair mechanism(s) of human renal tubular epithelial cells in response to various shock and injury. We have demonstrated that during renal injury, HO-1 may play a critical role in the repair mechanism(s) by regulating several genes, including angiogenic factors (Laxmanan & Pal et al, J Am Soc of Nephrology, 2005; Datta & Pal et al, Am Journal of Physiology, 2007).

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R03CA215926 (PAL, SOUMITRO) Jun 5, 2018 - Jun 30, 2021
    NIH
    CXCR3-B-mediated novel growth-inhibitory signals in breast cancer cells
    Role: Principal Investigator
  2. R01CA222355 (PAL, SOUMITRO) Jun 1, 2018 - May 31, 2024
    NIH
    Protective role of Honokiol in preventing c-Met-induced post-transplantation cancer
    Role: Principal Investigator
  3. R01CA193675 (PAL, SOUMITRO) Jan 1, 2016 - Dec 31, 2021
    NIH
    Novel Role(s) of Nrf2 in the Growth of Post-Transplantation Cancer
    Role: Principal Investigator
  4. R21CA191735 (PAL, SOUMITRO) Jul 15, 2015 - Jun 30, 2019
    NIH
    Novel Role of Honokiol in Preventing Cancer during Immune Suppression
    Role: Principal Investigator
  5. R21CA172946 (PAL, SOUMITRO) Sep 1, 2013 - Aug 31, 2017
    NIH
    Novel Therapeutic Targets For Calcineurin Inhibitor-Induced And mTOR-Mediated Can
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
Updating...
This operation might take several minutes to complete. Please do not close your browser.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Pal's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (257)
Explore
_
Co-Authors (25)
Explore
_
Similar People (59)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.